Gunnar Folprecht

University Hospital Carl Gustav Carus

Germany

Research Interests

Explore related searches

Professors in Germany Professors in Cancer Biology Cancer Biology professors in Germany

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (11)

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (6)

Stefan Kasper

Professor of Medical Oncology

GERMANY

View details

Stephanie Roessler

Professor (W3)

Ruprecht Karls Universität Heidelberg

GERMANY

View details

Sebastian Stintzing

Professor

Charité - Universitätsmedizin Berlin

GERMANY

View details

C. Benedikt Westphalen

GERMANY

View details

julien taieb

Professor Head of the department

Université Paris-Saclay

FRANCE

View details

Vanesa GREGORC

Candiolo Cancer Institute

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Gunnar Folprecht

Research Interests

Explore related searches

Contact this professor

Articles (11)

Geriatric assessment and the variance of treatment recommendations in geriatric patients with gastrointestinal cancer-a study in AIO oncologists.

Response to (K)RAS<sup>G12C</sup> and EGFR Inhibition in a Patient With <i>NRAS</i><sup>G12C</sup>-Mutated Rectal Cancer

Response to (K)RASG12C and EGFR Inhibition in a Patient With NRASG12C-Mutated Rectal Cancer

Adverse Events Associated with Encorafenib Plus Cetuximab in Patients with BRAFV600E-mutant Metastatic Colorectal Cancer: An in-depth Analysis of the BEACON CRC Study

Bcl-x<sub>L</sub> as prognostic marker and potential therapeutic target in cholangiocarcinoma.

Comprehensive genomic and epigenomic analysis in cancer of unknown primary guides molecularly-informed therapies despite heterogeneity

Survival after secondary liver resection in metastatic colorectal cancer: Comparing data of three prospective randomized European trials (LICC, CELIM, FIRE‐3)

Comprehensive cancer predisposition testing within the prospective MASTER trial identifies hereditary cancer patients and supports treatment decisions for rare cancers

Detecting drug resistance in pancreatic cancer organoids guides optimized chemotherapy treatment

Gene expression-based prediction of pazopanib efficacy in sarcoma

International Tailored Chemotherapy Adjuvant (ITACA) trial, a phase III multicenter randomized trial comparing adjuvant pharmacogenomic-driven chemotherapy versus standard adjuvant chemotherapy in completely resected stage II-IIIA non-small-cell lung cancer

Collaborators (6)

Stefan Kasper

Stephanie Roessler

Sebastian Stintzing

C. Benedikt Westphalen

julien taieb

Vanesa GREGORC

Make your next move.